Skip to content

This text should not show on a preview page

The information on this site is for healthcare professionals only.
Are you a healthcare professional?

No
This site is not currently optimised for Internet Explorer.
For best viewing, please use Chrome, Firefox, Edge, or Safari.
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Home
  • The untapped potential of pulmonary rehabilitation

Search results for Asthma

The untapped potential of pulmonary rehabilitation

The untapped potential of pulmonary rehabilitation

  • Asthma
  • barriers
  • COPD
  • intervention
  • Lung disease
  • non-pharmacological
  • Pulmonary rehabilitation
Innovation
European Respiratory Society Congress 2019

European Respiratory Society Congress 2019

Events
Where is the value in big data?

Where is the value in big data?

  • Big data
Innovation 5 min read
ERS 2018: Prof Richard Dekhuijzen on adherence

ERS 2018: Prof Richard Dekhuijzen on adherence

  • Adherance
Videos 2 min read
ERS 2018: Prof Richard Costello on LAMAs

ERS 2018: Prof Richard Costello on LAMAs

  • Asthma
  • Treatment
Videos 1 min read
ERS 2018: Prof Richard Dekhuijzen

ERS 2018: Prof Richard Dekhuijzen

  • Inhalers
  • Technology
Videos 2 min read
Research roundup: Antibiotic treatment in COPD exacerbations

Research roundup: Antibiotic treatment in COPD exacerbations

  • COPD
  • Treatment
Knowledge 5 min read
About Teva

About Teva

Teva
The pre-school child with chronic cough

The pre-school child with chronic cough

  • Asthma
  • Children
Knowledge 4 min read
Magnetic resonanse image of chest.

Interstitial lung disease

  • Diagnosis
  • Lung disease
Knowledge 6 min read
  • Let's talk  Contact
  • Let's talk  Legal notice
  • Let's talk  Privacy policy
  • Let's talk  Report Adverse Events
© 2020 Teva Pharmaceuticals Europe BV. All rights reserved. Reporting of suspected adverse events is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. To ensure correct adverse event reporting, healthcare professionals are encouraged to use the appropriate website for their National Authority.
Piet Heinkade 107, 1019 GM Amsterdam, The Netherlands.
Approval code: HQ/RESP/19/0001a Date of preparation: May 2019

This website uses cookies to ensure you get the best experience on our website. Learn more in our cookie policy

Thank you for your visit.
You are now leaving the website.
Do you wish to continue?